ArticleCureus2023
Preferences for Colorectal Cancer Screening Modalities Among the General Population in Saudi Arabia.
Article in Cureus, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Tailoring colorectal cancer screening: Knowledge, CRC screening acceptability, and practices among Jordanian and refugee populations.Journal of migration and health · 2026Article
- Colorectal Cancer Screening in Saudi Arabia:Saudi medical journal · 2026Review
- Assessing Adherence and Identifying Barriers to Colorectal Cancer Screening in the Adult General Populations of Saudi Arabia: A Nationwide Cross-Sectional Study.International journal of environmental research and public health · 2025Article
- Evaluating the implementation of colorectal cancer screening practices at King Abdul-Aziz Medical City, Riyadh.Journal of family medicine and primary care · 2025Article
- Exploring knowledge, attitude, practices and barriers toward colorectal cancer screening in the United Arab Emirates: a mixed-methods study.Frontiers in public health · 2025Article
- Mapping the Colorectal Cancer Patient Journey From the Oncologist Perspective in Saudi Arabia.Journal of multidisciplinary healthcare · 2025Article
- Diagnosis and Management of Colorectal Cancer in the Gulf Area: Current Practice and Future Suggestions from Expert Opinions.OncoTargets and therapy · 2025Review
- Barriers and Facilitators to Colorectal Cancer Screening: Providers' Perspective.Asian Pacific journal of cancer prevention : APJCP · 2024Article
- Positive Fecal Occult Blood Test and Colonoscopy With Histopathology Findings in Saudi Adults.Cureus · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundColorectal cancer (CRC) could be a leading explanation for cancer-related death. Numerous studies have shown the benefit of early screening for colorectal cancer in reducing mortality. Screening for colorectal cancer is a rational and cost-effective strategy for reducing the incidence of colorectal cancer and related mortality. Despite endorsement by academic and healthcare organizations, patient awareness and compliance with screening are low, partly due to patient-related barriers to screening.
aimThis study aimed to explore the preferred screening method for colorectal cancer in Saudi Arabia in general.
methodsThis is a cross-sectional study conducted among the Saudi adult population from September 2021 through February 2022. A self-developed questionnaire was distributed among the population using an online platform. Data were tabulated in Google Forms, and all statistical analyses were performed using SPSS version 26 (IBM Corp., Armonk, NY).
resultsDuring this study, data from 10,781 participants were analyzed. Among them, the most preferred screening modality for colorectal cancer was the stool fecal immunochemical test (41.7%) and the most suitable (33.5%). The most commonly mentioned qualities that influenced choosing a particular screening test were "how the test was performed" (50.4%).
conclusionBecause the stool fecal immunochemical test is the most preferred screening modality for colorectal cancer, this study could serve as a database to aid in the implementation of a colorectal cancer screening program that meets the preferences of the general population of Saudi Arabia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.